Unusual lipid structures selectively reduce the toxicity of amphotericin B.

31P nuclear magnetic resonance and the head group structure of phospholipids in membranes

1978 • 872 citations

Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

1985 • 412 citations

Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. I. Specificity of the membrane permeability changes induced by the polyene antibiotics

1974 • 330 citations

Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B

1983 • 300 citations

Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

1987 • 217 citations

Treatment of Murine Cryptococcosis with Liposome-Associated Amphotericin B

1982 • 205 citations

Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells

1984 • 194 citations

Novel multilayered lipid vesicles: comparison of physical characteristics of multilamellar liposomes and stable plurilamellar vesicles

1985 • 182 citations

Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes

1981 • 175 citations

Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B

1987 • 173 citations

Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study

1983 • 154 citations

Lipid phase transitions and drug interactions

1974 • 141 citations

Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.

1987 • 115 citations

Interaction of amphotericin B with membrane lipids as viewed by 2H-NMR

1984 • 48 citations